|
RC3H1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.111600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.439540E-02 |
| Normal-vs-Stage2 |
7.625400E-01 |
| Normal-vs-Stage3 |
7.728600E-01 |
| Normal-vs-Stage4 |
1.021040E-01 |
| Stage1-vs-Stage2 |
2.459400E-01 |
| Stage1-vs-Stage3 |
4.063800E-03 |
| Stage1-vs-Stage4 |
2.09799999995042E-06 |
| Stage2-vs-Stage3 |
6.156400E-01 |
| Stage2-vs-Stage4 |
1.827650E-01 |
| Stage3-vs-Stage4 |
1.635810E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.971980E-01 |
| Normal-vs-AfricanAmerican |
6.152400E-02 |
| Normal-vs-Asian |
1.792980E-01 |
| Caucasian-vs-AfricanAmerican |
9.448100E-04 |
| Caucasian-vs-Asian |
4.861600E-01 |
| AfricanAmerican-vs-Asian |
3.095700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.792200E-01 |
| Normal-vs-Female |
1.301180E-01 |
| Male-vs-Female |
1.581400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.161400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.243410E-01 |
| Normal-vs-Age(61-80Yrs) |
5.981400E-01 |
| Normal-vs-Age(81-100Yrs) |
9.139800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.131400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.077400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.378000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.956840E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.932800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.033200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.320580E-01 |
| Normal-vs-Grade 2 |
3.979100E-03 |
| Normal-vs-Grade 3 |
9.903400E-01 |
| Normal-vs-Grade 4 |
3.319800E-03 |
| Grade 1-vs-Grade 2 |
9.040400E-01 |
| Grade 1-vs-Grade 3 |
1.511990E-01 |
| Grade 1-vs-Grade 4 |
4.380900E-04 |
| Grade 2-vs-Grade 3 |
3.413200E-04 |
| Grade 2-vs-Grade 4 |
2.40179987009981E-10 |
| Grade 3-vs-Grade 4 |
3.239400E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.52420000000464E-05 |
| Normal-vs-ccB subtype |
3.450200E-01 |
| ccA subtype-vs-ccB subtype |
6.0642000310196E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.535600E-01 |
| Normal-vs-N1 |
5.346200E-01 |
| N0-vs-N1 |
4.147200E-01 |
|
|
